Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...
Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.
Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback